Boston Scientific Corporation vs Vanguard S&P 500 ETF — how do they compare? Boston Scientific Corporation trades at $51.1 (market cap $74.19B), while Vanguard S&P 500 ETF trades at $710.04. The key difference: Vanguard S&P 500 ETF is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | VOO | |
|---|---|---|
Market Cap | $74.19B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $108.14 | $710.71 |
52-Week Low | $42.63 | $580.93 |
Enterprise Value | $86.27B | — |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.
Read more on VOO →